Operating

Change in AR

Gilead Sciences Change in AR decreased by 140.2% to -$134.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 69.6%, from -$79.00M to -$134.00M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 7, 2026

How to read this metric

A decrease is generally positive as it indicates faster collection of cash from customers.

Detailed definition

This measures the change in the amount of money owed to the company by customers for goods or services delivered on cred...

Peer comparison

Standard metric for all companies; peers in medical devices monitor this closely to manage working capital cycles.

Metric ID: change_in_accounts_receivable

Historical Data

16 periods
 Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value-$41.00M-$699.00M$452.00M$372.00M$281.00M-$635.00M$612.00M-$220.00M$66.00M$29.00M-$162.00M-$72.00M-$79.00M$292.00M$333.00M-$134.00M
QoQ Change<-999%+164.7%-17.7%-24.5%-326.0%+196.4%-135.9%+130.0%-56.1%-658.6%+55.6%-9.7%+469.6%+14.0%-140.2%
YoY Change+785.4%+9.2%+64.5%-178.3%+110.4%-126.5%+67.3%-219.7%+906.9%+305.6%-69.6%
Range-$699.00M$612.00M
CAGR+37.1%
Avg YoY Growth+150.5%
Median YoY Growth+64.5%

Frequently Asked Questions

What is Gilead Sciences's change in ar?
Gilead Sciences (GILD) reported change in ar of -$134.00M in Q1 2026.
How has Gilead Sciences's change in ar changed year-over-year?
Gilead Sciences's change in ar decreased by 69.6% year-over-year, from -$79.00M to -$134.00M.
What does change in ar mean?
The change in money owed to the company by customers for past sales.